Page 56 - 2021 Taiwan Food and Drug Administration Annual Report
P. 56
DEXVH XULQH VDPSOH WHVWV WHVWV SHUIRUPHG 15 institutions in Taiwan at present to help
with non-urine specimens in suspected drug SURVHFXWLRQ SROLFH DQG LQYHVWLJDWLRQ DXWKRULWLHV
DQG FRQWUROOHG GUXJ FDVHV GUXJ VHL]HG HWF test non-urine specimens for drug abuse. In
and monthly compiled into the “Drug Abuse accordance with Article 9-3 of the “Enforcement
&DVH DQG 7HVWLQJ 6WDWLVWLFV ´ Rules of Narcotics Hazard Prevention Act,´
each inspection agency and institution should
Implementation Strategy report drug test results to the UDARS every
month. TFDA will count positive results of non-
I. Reporting mechanism for urine samples of suspected drug and controlled
healthcare facilities on drug drug cases on a monthly basis to provide
abuse reference for the development of drug control
strategies by various departments.
TFDA has established a Drug Abuse
Reporting System (DARS) to receive IV. Taiwan Emergency Depart-
information through drug abuse cases ment Drug Abuse Surveillance
reported monthly by healthcare facilities in
WKH FRXQWU\ WR REWDLQ WKH HSLGHPLRORJLFDO ,Q 7)'$ FRPPLVVLRQHG WKH ³5HLQ-
information of drug abuse cases. forced Monitoring Plan for NPS in Emergen-
F\ 'HSDUWPHQWV (' ´ WR FRQGXFW H[SDQGHG
II. Management and reporting of screening of urine samples of 150 NPS for
approved institutions for drug suspected drug poisoning cases in ED of med-
abuse urine tests ical institutions across the country. The results
of the expanded screening can be the reference
$V RI WKH HQG RI WKHUH ZHUH to diagnosis and treatment for emergency phy-
approved institutions for drug abuse urine VLFLDQV DV ZHOO DV WKH UHIHUHQFH IRU GUXJ DEXVH
tests and designated testing institutions in situation in country’s EDs.
the country. The approved testing institutions
will regularly submit the inspection results $FKLHYHPHQWV DQG %HQH¿WV
to the Urine Test for Drug Abuse Reporting
System (UDARS) on a monthly basis. I. Reporting situation of drug
TFDA conducted performance monitoring of abuse at healthcare facilities
approved institutions on a quarterly basis. In
D WRWDO RI FDVHV ZHUH KDQGOHG The analysis data of DARS showed that
WKHUH ZHUH FDVHV LQ WRWDO UHSRUWHG
III. Non-urine (Drug) testing and for drug abuse by healthcare facilities in
reporting upon drug abuse 2020. The top three types of drug abuse case
QXPEHU LQFOXGHG KHURLQ
According to the division of labor in drug PHWK DPSKHWDPLQH DQG
WHVWLQJ RI WKH 0LQLVWU\ RI -XVWLFH WKHUH DUH
54